Pancreatic Cancer Research

ResearcherUniversity of Nebraska Medical CenterActive in the last 2 years

Palanisamy Nallasamy

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-8962-2487; OpenAlex author ID A5054199277. Sources: OpenAlex.

Their work

Papers
14
Trials
0
Grants
0
Labs led
0
Collaborators
55
Papers, trials and grants by year

2020: 2 papers · 2021: 3 papers · 2022: 3 papers · 2023: none · 2024: 2 papers · 2025: none · 2026: 4 papers

Papers 14

  1. Targeting the DDX3/PAF1 axis enhances chemotherapy efficacy in pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.canlet.2026.218276↗
  2. SLC22A3/OCT3 drives serotonin-mediated stemness in pancreatic cancer. Co-author DOI 10.1016/j.celrep.2026.117387↗
  3. Distinct glycosyltransferase expression governs organ-specific survival in pancreatic cancer metastasis. Co-author DOI 10.1038/s41388-026-03896-5↗
  4. Targeting Oncomucin-Driven Immunosuppression Improves the Efficacy of K-ras G12D Inhibition in Pancreatic Cancer. Co-author DOI 10.1053/j.gastro.2026.04.041↗
  5. Secretory Trefoil Factor 1 (TFF1) promotes gemcitabine resistance through chemokine receptor CXCR4 in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1016/j.canlet.2024.217097↗
  6. Cancer-Associated Fibroblast Induces Acinar-to-Ductal Cell Transdifferentiation and Pancreatic Cancer Initiation Via LAMA5/ITGA4 Axis. Co-author DOI 10.1053/j.gastro.2023.12.018↗
  7. Small molecule inhibitor against onco-mucins disrupts Src/FosL1 axis to enhance gemcitabine efficacy in pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.canlet.2022.215922↗
  8. Reduction in O-glycome induces differentially glycosylated CD44 to promote stemness and metastasis in pancreatic cancer. Co-author DOI 10.1038/s41388-021-02047-2↗
  9. PAF1 cooperates with YAP1 in metaplastic ducts to promote pancreatic cancer. Co-author DOI 10.1038/s41419-022-05258-x↗
  10. Metabolic programming of distinct cancer stem cells promotes metastasis of pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/s41388-020-01518-2↗
  11. Selective inhibition of stemness through EGFR/FOXA2/SOX9 axis reduces pancreatic cancer metastasis. Co-author DOI 10.1038/s41388-020-01564-w↗
  12. Secretory Mucin 5AC Promotes Neoplastic Progression by Augmenting KLF4-Mediated Pancreatic Cancer Cell Stemness. Co-author DOI 10.1158/0008-5472.can-20-1293↗
  13. Global analysis of human glycosyltransferases reveals novel targets for pancreatic cancer pathogenesis. Co-author DOI 10.1038/s41416-020-0772-3↗
  14. RNA Polymerase II-Associated Factor 1 Regulates Stem Cell Features of Pancreatic Cancer Cells, Independently of the PAF1 Complex, via Interactions With PHF5A a… Co-author DOI 10.1053/j.gastro.2020.07.053↗

Closest collaborators

The 25 strongest of 55 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Surinder K. Batra · 13 shared papers, 2020–2026 · strength 2.13
  2. Moorthy Palanimuthu Ponnusamy · 13 shared papers, 2020–2026 · strength 1.99
  3. Jesse L. Cox · 9 shared papers, 2021–2026 · strength 1.56
  4. Sanchita Rauth · 10 shared papers, 2020–2026 · strength 1.55
  5. Zahraa Wajih Alsafwani · 5 shared papers, 2024–2026 · strength 1.13
  6. Rama Krishna Nimmakayala · 8 shared papers, 2020–2024 · strength 0.98
  7. Saravanakumar Marimuthu · 5 shared papers, 2021–2026 · strength 0.94
  8. Ashu Shah · 5 shared papers, 2021–2026 · strength 0.91
  9. Venkatesh Varadharaj · 4 shared papers, 2022–2026 · strength 0.85
  10. Frank Leon · 6 shared papers, 2020–2026 · strength 0.84
  11. Kavita B. Mallya · 5 shared papers, 2021–2026 · strength 0.83
  12. Subodh M. Lele · 5 shared papers, 2021–2026 · strength 0.78
  13. Pranita Atri · 4 shared papers, 2021–2026 · strength 0.66
  14. Satyanarayana Rachagani · 6 shared papers, 2020–2022 · strength 0.66
  15. Parthasarathy Seshacharyulu · 4 shared papers, 2021–2026 · strength 0.63
  16. Nivedeta Krishna Kumar · 3 shared papers, 2022–2026 · strength 0.58
  17. Kirtana Arikath · 2 shared papers, 2026 · strength 0.45
  18. Geoffrey A. Talmon · 2 shared papers, 2026 · strength 0.45
  19. Seema C. Parte · 3 shared papers, 2022–2024 · strength 0.43
  20. Seema Chugh · 3 shared papers, 2020–2022 · strength 0.35
  21. Saswati Karmakar · 3 shared papers, 2020–2022 · strength 0.35
  22. Mokenge Peter Malafa · 2 shared papers, 2021–2026 · strength 0.34
  23. Sushil Kumar K · 3 shared papers, 2020–2022 · strength 0.33
  24. Lynette M. Smith · 3 shared papers, 2021–2022 · strength 0.33
  25. Jean L. Grem · 2 shared papers, 2021–2026 · strength 0.32

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.